Skip to main content
SpringerLink
Log in

Computed tomography in staging of patients with melanoma metastatic to the regional nodes

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: This study addresses the yield and clinical impact of computed tomography (CT) imaging in otherwise asymptomatic patients with stage III melanoma metastatic to the regional nodes.

Methods: The database from the University of Michigan Mutlidisciplinary Melanoma Clinic was reviewed and identified 127 asymptomatic patients with stage III melanoma (regional nodal disease) who received CT scans of the head, chest, abdomen, and/or pelvis. Scans were confirmed as true positive, false positive, and normal.

Results: Four hundred twenty-six head and body CT scans were performed at the time of presentation of stage III disease. Twenty patients had a true-positive CT scan revealing unsuspected metastases. Fifteen patients had abnormal CT scans subsequently shown to be a benign process or second malignancy. The incidence of true-positive CT scans was not different between the groups of patients who had clinically apparent versus occult nodal disease. There was a significantly higher incidence of abdominal and pelvic metastatic sites identified by CT scan in patients with inguinal nodal disease compared with axillary or head and neck node-positive patients.

Conclusions: The yield of detection of unsuspected metastases by CT scans in asymptomatic patients with stage III melanoma was not insignificant. Because patients with resected stage III disease are recommended to have adjuvant interferon-α for 1 year, CT staging plays an important role in identifying appropriate candidates for treatment. The toxicity of interferon-α therapy is not insignificant. The value of routine CT in asymptomatic patients with nodal metastasis deserves further prospective study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Balch CM, Cascinelli N, Drzewiecki KT, Eldh J, MacKie RM, McCarthy WH, et al. A comparison of prognostic factors world-wide. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S, eds.Cutaneous melanoma. Philadelphia: JB Lippincott, 1992:188–99.

    Google Scholar 

  2. Cohen MH, Ketcham AS, Felix EL, Li SH, Tomaszewski MM, Costa J, Rabson AS, et al. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma.Ann Surg 1977;186:635–42.

    CAS  PubMed  Google Scholar 

  3. Callery C, Cochran AJ, Roe DJ, Rees W, Nathanson SD, Benedetti JK, Elashoff RM, et al. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.Ann Surg 1982;196:69–75.

    CAS  PubMed  Google Scholar 

  4. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases.Arch Surg 1989;124:1051–5.

    CAS  PubMed  Google Scholar 

  5. Bevilacqua RG, Coit DG, Rogatko A, Younes RN, Breenan MF. Axillary dissection in melanoma: prognostic variables in nodepositive patients.Ann Surg 1990;212:125–31.

    CAS  PubMed  Google Scholar 

  6. Malignant melanoma of the skin (excluding eyelid). In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds.American Joint Committee on Cancer Manual for Staging of Cancer. Philadelphia: JB Lippincott, 1992:143–8.

    Google Scholar 

  7. Johnson TM, Smith JW II, Nelson BR, Chang AE. Current therapy for cutaneous melanoma.J Am Acad Dermatol 1995;32:689–707.

    Article  CAS  PubMed  Google Scholar 

  8. Balch CM, Soong S, Murad TM, Smith JW, Maddox WA, Durant JR. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).J Clin Oncol 1983;1:126–34.

    CAS  PubMed  Google Scholar 

  9. Amer MH, Al-Sarraf M, Vaitkevicius VK. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma.Surg Gynecol Obstet 1979;149:687–92.

    CAS  PubMed  Google Scholar 

  10. Stehlin JS, Hills WJ, Rufino C. Disseminated melanoma: biologic behavior and treatment.Arch Surg 1967;94:495–501.

    PubMed  Google Scholar 

  11. Buzaid AC, Sandler AB, Mani S, Curtis AM, Poo WJ, Bolongnia JL, Ariyan S, et al. Role of computed tomography in the staging of primary melanoma.J Clin Oncol 1993;11:638–43.

    CAS  PubMed  Google Scholar 

  12. Khansur T, Sanders J, Das SK. Evaluation of staging work-up in malignant melanoma.Arch Surg 1989;124:847–9.

    CAS  PubMed  Google Scholar 

  13. Roth JA, Eiiber FR, Bennet LR, Morton DL. Radionuclide photoscanning. Usefulness in preoperative evaluation in melanoma patients.Arch Surg 1975;110:1211–12.

    CAS  PubMed  Google Scholar 

  14. Thomas JH, Panousopoulous D, Liesmann GE, Jewell WR, Preston DF. Scintiscans in the evaluation of patients with malignant melanoma.Surg Gynecol Obstet 1979;149:574–76.

    CAS  PubMed  Google Scholar 

  15. Buzaid AC, Tinoco L, Ross MI, Legha SS, Benjamine RS. Role of computed tomography in the staging of patients with local-regional metastases of melanoma.J Clin Oncol 1995;13:2104–8.

    CAS  PubMed  Google Scholar 

  16. Galicich JH, Sundaresan N, Arbit E, Passe S. Surgical treatment of single brain metastasis: factors associated with survival.Cancer 1980;45:381–6.

    CAS  PubMed  Google Scholar 

  17. Brega K, Robinson WA, Winston K, Wittenberg W. Surgical treatment of brain metastases in malignant melanoma.Cancer 1990;66:2105–10.

    CAS  PubMed  Google Scholar 

  18. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin-2.JAMA 1994;271:907–13.

    CAS  PubMed  Google Scholar 

  19. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen RA, Moen R, et al. Gene transfer into humans; immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.N Engl J Med 1990;323:570–8.

    CAS  PubMed  Google Scholar 

  20. Pockaj BA, Sherry RM, Wei JP, Yannelli JR, Carter CS, Letiman SF, Carasquillo JA, et al. Localization of 111 indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy.Cancer 1994;73:1731–7.

    CAS  PubMed  Google Scholar 

  21. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.Proc Natl Acad Sci U S A 1993;90:11307–11.

    CAS  PubMed  Google Scholar 

  22. Vile RG, Hart IR. Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA.Cancer Res 1993;53:3860–4.

    CAS  PubMed  Google Scholar 

  23. Veronesi U, Adams J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, et al. Delayed regional lymph node dissection in stage I malignant melanoma of the skin of the lower extremities.Cancer 1982;49:2420–30.

    CAS  PubMed  Google Scholar 

  24. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.Mayo Clin Proc 1986;61:697–705.

    CAS  PubMed  Google Scholar 

  25. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392–9.

    CAS  PubMed  Google Scholar 

  26. Morton DL, Wen DR, Foshag LJ, Essner R, Cochran A. Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck.J Clin Oncol 1993;11:1751–6.

    CAS  PubMed  Google Scholar 

  27. Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, et al. Minimal-access surgery for staging of malignant melanoma.Arch Srug 1995;130:654–8.

    CAS  Google Scholar 

  28. Ross MI, Reintgen D, Balch CM. Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.Semin Surg Oncol 1993;9:219–23.

    CAS  PubMed  Google Scholar 

  29. Reintgen D, Cruse CW, Wells K, Berman C, Fenske N, Glass F, Schroer K, et al. The orderly progression of melanoma nodal metastases.Ann Surg 1994;220:759–67.

    CAS  PubMed  Google Scholar 

  30. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.J Clin Oncol 1996;14:7–17.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Department of Dermatology, University of Michigan Medical Center, and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA

    Timothy M. Johnson MD, Darrell J. Fader MD & K. Renee Hamlet MD

  2. the Department of Surgery, University of Michigan Medical Center, and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA

    Alfred E. Chang MD, Alan Yahanda MD & Vernon K. Sondak MD

  3. the Department of Medicine, University of Michigan Medical Center, and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, USA

    John W. Smith II MD

Authors
  1. Timothy M. Johnson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Darrell J. Fader MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfred E. Chang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alan Yahanda MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John W. Smith II MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Renee Hamlet MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vernon K. Sondak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Johnson, T.M., Fader, D.J., Chang, A.E. et al. Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Annals of Surgical Oncology 4, 396–402 (1997). https://doi.org/10.1007/BF02305552

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02305552

Key Words

Search

Navigation